For the quarter ended June 2026, Viatris (VTRS) reported revenue of $3.76 billion, up 4.9% over the same period last year. EPS came in at $0.69, compared to $0.62 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $3.68 billion, representing a surprise of +2.19%. The company delivered an EPS surprise of +11.29%, with the consensus EPS estimate being $0.62.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Viatris performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Developed Markets: $2.19 billion versus the two-analyst average estimate of $2.18 billion. The reported number represents a year-over-year change of +3.5%. Net Sales- Greater China: $713.8 million versus $631.67 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +21.2% change. Revenues- Other revenues: $10.9 million versus $11.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.8% change. Net Sales- Emerging Markets: $542.3 million versus the two-analyst average estimate of $558.47 million. The reported number represents a year-over-year change of -2.3%. Revenues- Total Net Sales: $3.75 billion compared to the $3.65 billion average estimate based on two analysts. The reported number represents a change of +5% year over year. Net Sales- JANZ: $296.1 million versus the two-analyst average estimate of $285.14 million. The reported number represents a year-over-year change of -3.1%.View all Key Company Metrics for Viatris here>>>
Shares of Viatris have returned +5.9% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Viatris Inc. (VTRS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).